TRIB — Trinity Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Trinity Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	27.3	25.9	6.58	3.69	5.17
Net Total Accounts Receivable
Net Total Receivables	24.6	15.7	15.7	13	14.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	83.3	72.7	46.7	39	41.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.55	5.92	5.68	1.89	4.62
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	130	119	92.1	59.4	103
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	27.1	100	17.3	15	32.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	133	119	94.3	83.4	138
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-2.22	-0.319	-2.18	-23.9	-35.2
Total Liabilities & Shareholders' Equity	130	119	92.1	59.4	103
Total Common Shares Outstanding